U.S. flag

An official website of the United States government

NM_183050.4(BCKDHB):c.36C>T (p.Leu12=) AND Maple syrup urine disease type 1B

Germline classification:
Likely benign (1 submission)
Last evaluated:
Mar 29, 2021
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001836026.1

Allele description [Variation Report for NM_183050.4(BCKDHB):c.36C>T (p.Leu12=)]

NM_183050.4(BCKDHB):c.36C>T (p.Leu12=)

Gene:
BCKDHB:branched chain keto acid dehydrogenase E1 subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q14.1
Genomic location:
Preferred name:
NM_183050.4(BCKDHB):c.36C>T (p.Leu12=)
HGVS:
  • NC_000006.12:g.80106729C>T
  • NG_009775.2:g.5103C>T
  • NM_000056.5:c.36C>T
  • NM_001318975.1:c.-15+46C>T
  • NM_183050.4:c.36C>TMANE SELECT
  • NP_000047.1:p.Leu12=
  • NP_898871.1:p.Leu12=
  • NC_000006.11:g.80816446C>T
  • NM_183050.2:c.36C>T
  • NR_134945.2:n.59C>T
Links:
dbSNP: rs1464497822
NCBI 1000 Genomes Browser:
rs1464497822
Molecular consequence:
  • NM_001318975.1:c.-15+46C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NR_134945.2:n.59C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000056.5:c.36C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_183050.4:c.36C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Maple syrup urine disease type 1B (MSUD1B)
Synonyms:
MSUD type IB; MSUD type 3 (formerly); MSUD due to deficiency of e1-beta subunit of branched-chain alpha-keto acid dehydrogenase complex
Identifiers:
MONDO: MONDO:0023692; MedGen: C2930990; OMIM: 620698

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002077417Natera, Inc.
no assertion criteria provided
Likely benign
(Mar 29, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002077417.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024